Metoclopramide Injection, Solution
Product Images NDC 51662-1288

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Metoclopramide (NDC 51662-1288). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2 mL Vial Label (1006420 0409 3414 18 Metoclopramide Vial)

This is a description of a drug package containing a single-use vial with 2 mL of Metoclopramide Inj., USP B. The National Drug Code of the product is 0409-3414-18. The drug has a concentration of 10 mg/2 mL (5 mg/mL) and is intended only for prescription use for intramuscular or intravenous administration. The manufacturer of the drug is Hospira and the drug code is RL-5011. The address of the manufacturer is Lake Forest, IL 60045 USA.*

FDA Label Image

Boxed Warning (Boxed Warning)

Metoclopramide is a medication that can cause Tardive Dyskinesia, a serious and irreversible movement disorder. The risk of Tardive Dyskinesia increases with the duration of treatment and the total cumulative dose. If signs or symptoms of Tardive Dyskinesia appear, the medication should be discontinued, as there is no known treatment for this condition. Treatment with Metoclopramide for more than 12 weeks should be avoided, except in rare cases where the benefits outweigh the risk. (Note: has split some words and sentences, but the meaning is clear.)*

FDA Label Image

Clinical Tabel 1 (Clinical Pharm 1)

This is a description of a drug's parameters. The drug has a volume of distribution (vd) of approximately 3.5 liters per kilogram. The plasma protein binding of the drug is around 30%. The drug has a half-life of 5 hours and 6 minutes. Its oral bioavailability is 80% with a variability of 15.5%.*

FDA Label Image

Clinical Tabel 2 (Clinical Pharm 2)

This appears to be a table of pharmacokinetic data for two different doses of a drug administered by IV. The table shows information such as the dose, reference dose, route of administration, peak concentration (Cmax), and the time it takes to reach maximum concentration (hr). There are also values for clearance and volume of distribution (Vd). However, the table is incomplete and some values are not clear, so it is difficult to determine much more about the drug or its effects without additional information.*

FDA Label Image

How Supplied Logo (How Supplied Logo)

FDA Label Image

How Supplied Tabel (How Supplied)

This text is describing the unit of sale and concentration for a certain medication. The NDC (National Drug Code) number is 0409-3414-01 and the medication is available in a concentration of 10 mg/2 mL.*

FDA Label Image

Logo Spl (Logo Spl)

FDA Label Image

Med Guide Logo (Med Guide Logo)

FDA Label Image

Structure (Structure)

This appears to be a chemical formula with molecular weight information. Without more context or knowledge of chemistry, it is difficult to provide a more specific or useful description.*

FDA Label Image

Serialized Label (Serialized 51662 1288 1 Metoclopramide)

FDA Label Image

Serialized Vial Label 51662 1288 1 March 2021

FDA Label Image

Vial Label 51662 1288 1 March 2021 Update

This text describes a label for a 2mL vial that will be marked with variable data in black on a white background using a 6 point B Medium font (minimum 4.5 point). The label will also include a vertical barcode on the right side, without a required quiet zone, and will not include human readable information except for the Canadian market. The unwind direction for the label is #4.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.